Farzin Fath‐Ordoubadi

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni et al. · The Lancet · 2018 · 761 citations

Endovascular Technique, Cardiovascular Disease, Randomised Superiority Trial +8

Clinical outcomes of state-of-the-art percutaneous coronary revascularization in patients with de novo three vessel disease: 1-year results of the SYNTAX II study

Javier Escaned, Carlos Collet, Nicola Ryan et al. · European Heart Journal · 2017 · 289 citations · Full text

A Large, Refractory Nosocomial Outbreak of Klebsiella pneumoniae Carbapenemase-Producing Escherichia coli Demonstrates Carbapenemase Gene Outbreaks Involving Sink Sites Require Novel Approaches to Infection Control

Valérie Decraene, Hang Phan, Ryan George et al. · Antimicrobial Agents and Chemotherapy · 2018 · 138 citations · Full text

Longitudinal stent deformation: a retrospective analysis of frequency and mechanisms

Paul D. Williams, Mamas A. Mamas, Kenneth Morgan et al. · EuroIntervention · 2012 · 136 citations

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak et al. · JACC: Cardiovascular Interventions · 2019 · 110 citations

Percutaneous Coronary Intervention, Cardiovascular Disease, Clinical Implication +10